Genomic Health, Inc. (NASDAQ:GHDX)

CAPS Rating: 5 out of 5

A life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions.

Recs

1
Player Avatar Dormin111ob (95.46) Submitted: 7/13/2010 11:04:46 PM : Underperform Start Price: $12.91 GHDX Score: +5.97

Losing money. Long slide downward.

Featured Broker Partners


Advertisement